AF
MDT icon

Arrow Financial’s Medtronic MDT Stock Holding History

Arrow Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-999
Closed -$89.9K – 259
2024
Q3 		$89.9K Sell
999
-5
-0.5% -$421 0.01% 198
2024
Q2 		$79K Sell
1,004
-40
-4% -$3.28K 0.01% 192
2024
Q1 		$91K Sell
1,044
-32
-3% -$2.73K 0.01% 186
2023
Q4 		$88.6K Sell
1,076
-6
-0.6% -$457 0.01% 185
2023
Q3 		$84.8K Sell
1,082
-265
-20% -$22.2K 0.01% 188
2023
Q2 		$119K Sell
1,347
-37
-3% -$3.19K 0.01% 169
2023
Q1 		$112K Sell
1,384
-250
-15% -$20.4K 0.01% 174
2022
Q4 		$127K Sell
1,634
-75
-4% -$6.08K 0.02% 168
2022
Q3 		$137K Sell
1,709
-587
-26% -$52.8K 0.02% 163
2022
Q2 		$207K Sell
2,296
-45
-2% -$4.56K 0.03% 150
2022
Q1 		$260K Sell
2,341
-18,900
-89% -$2M 0.03% 155
2021
Q4 		$2.2M Hold
21,241
– – 0.26% 74
2021
Q3 		$2.66M Buy
21,241
+12,150
+134% +$1.57M 0.34% 56
2021
Q2 		$1.13M Sell
9,091
-47
-0.5% -$5.9K 0.14% 95
2021
Q1 		$1.08M Sell
9,138
-4,782
-34% -$560K 0.14% 93
2020
Q4 		$1.63M Sell
13,920
-30
-0.2% -$3.3K 0.32% 71
2020
Q3 		$1.45M Sell
13,950
-87
-0.6% -$8.74K 0.31% 69
2020
Q2 		$1.29M Sell
14,037
-160
-1% -$15.3K 0.28% 74
2020
Q1 		$1.28M Sell
14,197
-100
-0.7% -$10.6K 0.3% 65
2019
Q4 		$1.62M Sell
14,297
-2,587
-15% -$284K 0.32% 71
2019
Q3 		$1.83M Sell
16,884
-110
-0.6% -$11.5K 0.38% 65
2019
Q2 		$1.66M Buy
16,994
+5,900
+53% +$539K 0.36% 66
2019
Q1 		$1.01M Hold
11,094
– – 0.23% 92
2018
Q4 		$1.01M Sell
11,094
-37
-0.3% -$3.46K 0.26% 88
2018
Q3 		$1.09M Buy
11,131
+5,660
+103% +$523K 0.23% 94
2018
Q2 		$468K Hold
5,471
– – 0.11% 135
2018
Q1 		$439K Sell
5,471
-35
-0.6% -$2.89K 0.1% 134
2017
Q4 		$444K Buy
5,506
+120
+2% +$9.61K 0.1% 132
2017
Q3 		$418K Sell
5,386
-1,413
-21% -$117K 0.1% 132
2017
Q2 		$604K Hold
6,799
– – 0.14% 119
2017
Q1 		$548K Sell
6,799
-197
-3% -$15.4K 0.13% 123
2016
Q4 		$499K Sell
6,996
-463
-6% -$36.4K 0.12% 120
2016
Q3 		$645K Hold
7,459
– – 0.16% 108
2016
Q2 		$647K Sell
7,459
-417
-5% -$33.7K 0.17% 111
2016
Q1 		$591K Buy
7,876
+132
+2% +$9.94K 0.16% 112
2015
Q4 		$595K Sell
7,744
-455
-6% -$34.3K 0.16% 109
2015
Q3 		$549K Sell
8,199
-255
-3% -$18.8K 0.16% 109
2015
Q2 		$626K Sell
8,454
-5,661
-40% -$433K 0.17% 119
2015
Q1 		$1.1M Buy
14,115
+4,980
+55% +$377K 0.3% 93
2014
Q4 		$659K Sell
9,135
-1,030
-10% -$71.5K 0.18% 119
2014
Q3 		$629K Sell
10,165
-1,075
-10% -$68.3K 0.17% 128
2014
Q2 		$717K Buy
11,240
+35
+0.3% +$2.13K 0.19% 128
2014
Q1 		$689K Sell
11,205
-1,475
-12% -$85.9K 0.2% 123
2013
Q4 		$728K Hold
12,680
– – 0.21% 115
2013
Q3 		$675K Sell
12,680
-145
-1% -$7.8K 0.21% 113
2013
Q2 		$661K Buy
+12,825
New +$634K 0.21% 113

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrow Financial's MDT Position: Q4 2024 in Review

Arrow Financial sold out of Medtronic (MDT) in Q4 2024, closing a stake of 999 shares — an estimated $89.9K sold.

Arrow Financial first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $2.66M in Q3 2021. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Arrow Financial reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Arrow Financial sold 999 Medtronic shares in Q4 2024, an estimated $89.9K.
  • Arrow Financial first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
  • Arrow Financial's Medtronic position peaked at $2.66M in Q3 2021.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.